The emergence of GLP-1 receptor agonists, including medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), has revolutionized the treatment of diabetes and obesity. These medications have gained widespread attention for their remarkable effectiveness in promoting weight loss and improving metabolic health. However, as more individuals begin using these treatments, an important question arises: How do GLP-1 medications affect mental health and emotional well-being?

The back-to-school season brings excitement and anticipation, but for families navigating ADHD, it can also trigger concerns about focus, organization, and academic performance. As backpacks are packed and schedules reset, parents often wonder: How can I best support my child's success this school year?

Many people begin their mental health journey in therapy, finding insight, growth, and healing through that powerful relationship. But for some, therapy alone doesn’t quite relieve the weight they carry. It’s a common and understandable experience—one that doesn’t reflect a personal failure, but rather a signal that another form of support might be helpful.

We recognize that recovery from addiction requires a comprehensive, personalized approach—one that often includes Medication-Assisted Treatment (MAT) as a vital component.